As of 2025-12-25, the Relative Valuation of Amphastar Pharmaceuticals Inc (AMPH) is 66.54 USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.81 USD, the upside of Amphastar Pharmaceuticals Inc based on Relative Valuation is 148.2%.
The range of the Relative Valuation is 27.01 - 128.29 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 28.2x | 11.6x |
| Forward P/E multiples | 22.4x - 39.5x | 32.3x |
| Fair Price | 27.01 - 128.29 | 66.54 |
| Upside | 0.8% - 378.5% | 148.2% |
| Date | P/E |
| 2025-12-23 | 10.89 |
| 2025-12-22 | 11.25 |
| 2025-12-19 | 10.95 |
| 2025-12-18 | 10.91 |
| 2025-12-17 | 10.73 |
| 2025-12-16 | 10.54 |
| 2025-12-15 | 10.83 |
| 2025-12-12 | 10.40 |
| 2025-12-11 | 10.66 |
| 2025-12-10 | 10.58 |
| 2025-12-09 | 10.56 |
| 2025-12-08 | 10.71 |
| 2025-12-05 | 11.02 |
| 2025-12-04 | 11.18 |
| 2025-12-03 | 11.35 |
| 2025-12-02 | 10.98 |
| 2025-12-01 | 11.30 |
| 2025-11-28 | 11.40 |
| 2025-11-26 | 11.26 |
| 2025-11-25 | 11.40 |
| 2025-11-24 | 10.99 |
| 2025-11-21 | 10.71 |
| 2025-11-20 | 10.44 |
| 2025-11-19 | 10.44 |
| 2025-11-18 | 10.66 |
| 2025-11-17 | 10.71 |
| 2025-11-14 | 10.73 |
| 2025-11-13 | 10.85 |
| 2025-11-12 | 11.46 |
| 2025-11-11 | 11.18 |
| 2025-11-10 | 10.75 |
| 2025-11-07 | 9.89 |
| 2025-11-06 | 9.97 |
| 2025-11-05 | 10.42 |
| 2025-11-04 | 10.40 |
| 2025-11-03 | 10.41 |
| 2025-10-31 | 10.50 |
| 2025-10-30 | 10.15 |
| 2025-10-29 | 9.98 |
| 2025-10-28 | 9.95 |
| 2025-10-27 | 9.90 |
| 2025-10-24 | 10.09 |
| 2025-10-23 | 10.18 |
| 2025-10-22 | 10.09 |
| 2025-10-21 | 9.99 |
| 2025-10-20 | 9.77 |
| 2025-10-17 | 9.79 |
| 2025-10-16 | 9.56 |
| 2025-10-15 | 9.53 |
| 2025-10-14 | 9.82 |